Literature DB >> 16169915

The precision of longitudinal lung function measurements: monitoring and interpretation.

E Hnizdo1, L Yu, L Freyder, M Attfield, J Lefante, H W Glindmeyer.   

Abstract

BACKGROUND: The efficacy of decision making based on longitudinal spirometric measurements depends critically on the precision of the available data, which is determined by the magnitude of the within-person variation. AIMS: Firstly, to describe and investigate two statistical methods-a pairwise estimate of within-person standard deviation s(p) and the reliability coefficient G-for use in the monitoring of precision of longitudinal measurements of forced expiratory volume in one second (FEV1). Secondly, to investigate the effect of longitudinal data precision on the detectable excess rate of decline in FEV1.
METHODS: The authors "monitored" retrospectively on a yearly basis the magnitude of the within-person variation s(p) and the coefficient G in 11 workplace based spirometric monitoring programmes conducted from 1987 to 2001 on 12 729 workers in various industrial plants.
RESULTS: The plant-specific mean values s(p) (range 122-166 ml) and G (range 0.88-0.95), averaged over all years of follow up, correlated well with the plant-specific within-person standard deviation s(r) (range 130-177 ml) estimated from all longitudinal data. The correlations were 0.90 for s(p) and 0.68 for G. The average precision of the longitudinal FEV1 measurements affected the duration of follow up needed to identify a "true" excess rate of decline in FEV1 in an individual.
CONCLUSIONS: The results show that monitoring of longitudinal spirometry data precision (1) allows that data precision can be improved or maintained at levels that allow individuals with a rapid decline to be identified at an earlier age; and (2) attaches a measure of precision to the data on which decision making is based.

Entities:  

Mesh:

Year:  2005        PMID: 16169915      PMCID: PMC1740862          DOI: 10.1136/oem.2004.018424

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  28 in total

1.  Assessment of reliability of lung function screening programs or longitudinal studies.

Authors:  E Hnizdo; G Churchyard; D Barnes; R Dowdeswell
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

2.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

3.  Repeated measures of FEV1 over six to twelve months: what change is abnormal?

Authors:  Mei-Lin Wang; Edward L Petsonk
Journal:  J Occup Environ Med       Date:  2004-06       Impact factor: 2.162

4.  ERS/ATS workshop on longitudinal analysis of pulmonary function data, Barcelona, September 1995.

Authors:  B Rijcken; J P Schouten; S T Weiss; J H Ware
Journal:  Eur Respir J       Date:  1997-03       Impact factor: 16.671

5.  Analysis of airspace and interstitial mononuclear cell populations in human diffuse interstitial lung disease.

Authors:  G S Davis; A R Brody; J E Craighead
Journal:  Am Rev Respir Dis       Date:  1978-07

6.  Longitudinal observations. Their usefulness and limitations with special reference to the forced expiratory volume.

Authors:  G Berry
Journal:  Bull Physiopathol Respir (Nancy)       Date:  1974 Sep-Oct

7.  Planning a longitudinal study. I. Sample size determination.

Authors:  J J Schlesselman
Journal:  J Chronic Dis       Date:  1973-09

Review 8.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

9.  Reliability of blood pressure measurements: implications for designing and evaluating programs to control hypertension.

Authors:  D S Shepard
Journal:  J Chronic Dis       Date:  1981

10.  Airflow obstruction attributable to work in industry and occupation among U.S. race/ethnic groups: a study of NHANES III data.

Authors:  Eva Hnizdo; Patricia A Sullivan; Ki Moon Bang; Gregory Wagner
Journal:  Am J Ind Med       Date:  2004-08       Impact factor: 2.214

View more
  6 in total

1.  Limits of longitudinal decline for the interpretation of annual changes in FEV1 in individuals.

Authors:  Eva Hnizdo; Kanta Sircar; Tieliang Yan; Philip Harber; James Fleming; Henry W Glindmeyer
Journal:  Occup Environ Med       Date:  2007-05-03       Impact factor: 4.402

2.  Lung function in oil spill responders 4-6 years after the Deepwater Horizon disaster.

Authors:  Kaitlyn G Lawrence; Alexander P Keil; Stavros Garantziotis; David M Umbach; Patricia A Stewart; Mark R Stenzel; John A McGrath; W Braxton Jackson; Richard K Kwok; Matthew D Curry; Lawrence S Engel; Dale P Sandler
Journal:  J Toxicol Environ Health A       Date:  2020-04-05

3.  Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study.

Authors:  David Taylor-Robinson; Margaret Whitehead; Finn Diderichsen; Hanne Vebert Olesen; Tania Pressler; Rosalind L Smyth; Peter Diggle
Journal:  Thorax       Date:  2012-05-03       Impact factor: 9.139

4.  Spirometry Longitudinal Data Analysis Software (SPIROLA) for Analysis of Spirometry Data in Workplace Prevention or COPD Treatment.

Authors:  Eva Hnizdo; Tieliang Yan; Artak Hakobyan; Paul Enright; Lu-Ann Beeckman-Wagner; John Hankinson; James Fleming; Edward Lee Petsonk
Journal:  Open Med Inform J       Date:  2010-07-08

5.  A long term study of pulmonary function among US refractory ceramic fibre workers.

Authors:  Roy T McKay; Grace K LeMasters; Timothy J Hilbert; Linda S Levin; Carol H Rice; Eric K Borton; James E Lockey
Journal:  Occup Environ Med       Date:  2010-08-25       Impact factor: 4.402

6.  Diagnostic approach in cases with suspected work-related asthma.

Authors:  Tor B Aasen; P Sherwood Burge; Paul K Henneberger; Vivi Schlünssen; Xaver Baur
Journal:  J Occup Med Toxicol       Date:  2013-06-14       Impact factor: 2.646

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.